Faisal Ghiath Sukhtian

OTLK

Faisal Ghiath Sukhtian serves as director at Outlook Therapeutics, Inc. (OTLK). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$113.9K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$113.9K

Companies Traded

OTLK

Active Period

Dec 2021 – May 2026

3 total trades

Most Recent

Buy OTLK

May 27, 2026 · $50.0K

Faisal Ghiath Sukhtian's Insider Trading at Outlook Therapeutics, Inc. (OTLK)

Buys

3 · $113.9K

Sells

0 · $0.00

Total Shares Bought

170,174

Total Shares Sold

OTLK Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 27, 2026	Buy	122,174	$0.41	$50.0K	125,574
Oct 11, 2022	Buy	30,000	$1.29	$38.7K	68,000
Dec 2, 2021	Buy	18,000	$1.40	$25.2K	38,000

Related Insiders

Yezan Munther Haddadin

director

OTLKBuy · Jun 3, 2026

Ghiath M. Sukhtian

director, 10 percent owner:

OTLKBuy · Jun 1, 2026

HILZINGER KURT J

director

OTLKBuy · May 27, 2026

THURMAN RANDY H

director

OTLKBuy · May 27, 2026

Explore More Insider Trading Data

OTLK Insider Trading Activity

View all insider trades at Outlook Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity